| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.15 | 1e-05 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0004 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.1 | 0.0006 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0007 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0008 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0008 |